secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2026-08-10T21:15:17+00:00
Accession:  0001829126-26-008543
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc reports Q2 2026 net loss of $14.2M; confirms Aug 12 Phase 2a NEO100 topline data
--------------------------------------------------------------------------------

- Net loss $14.2M ($0.58/sh) vs $5.7M ($0.30/sh) in Q2 2025; R&D up to $2.6M from $0.7M.
- Cash $2.0M at 6/30/26; undrawn $10M HCWG credit line; $44.5M available under Mast Hill facility.
- Received UAE IND approvals for NEO100 (covering all programs) and NEO212 (Phase 2) in June 2026.
- FDA written feedback on NEO212 CMC and tablet formulation received July 2026; official minutes expected Aug 2026.
- Phase 2a NEO100 topline results to be presented Aug 12, 2026; Nasim Shomali appointed to board effective July 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912626008543/0001829126-26-008543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912626008543/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-008543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer